Press release
Synovial Sarcoma - Pipeline Review, H2 2018| Key players : Epizyme , GlaxoSmithKline Plc,Ignyta , Immune Design ,Immunocore
Synovial Sarcoma
Request a sample report @ https://www.htfmarketreport.com/sample-report/1301536-synovial-sarcoma-pipeline-review-5
Synovial Sarcoma - Pipeline Review, H2 2018
HTF’s latest Pharmaceutical and Healthcare disease pipeline guide Synovial Sarcoma - Pipeline Review, H2 2018, provides an overview of the Synovial Sarcoma (Oncology) pipeline landscape.
Synovial sarcoma is a soft tissue tumor occurring in the biphasic or monophasic type and consisting of epithelial and/or spindle cell components. Symptoms include swelling, mass that may or may not be accompanied by pain and limping or difficulty using legs, arms, hands or feet. Treatment includes surgery, radiation therapy and chemotherapy.
Report Highlights
HTF’s Pharmaceutical and Healthcare latest pipeline guide Synovial Sarcoma - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Synovial Sarcoma (Oncology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
The Synovial Sarcoma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Synovial Sarcoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I and Preclinical stages are 1, 1, 9, 4 and 9 respectively. Similarly, the Universities portfolio in Phase I stages comprises 2 molecules, respectively.
Synovial Sarcoma (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from HTF’sproprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1301536
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Synovial Sarcoma (Oncology).
- The pipeline guide reviews pipeline therapeutics for Synovial Sarcoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Synovial Sarcoma (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Synovial Sarcoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Synovial Sarcoma (Oncology)
Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Synovial Sarcoma (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Synovial Sarcoma (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Companies Mentioned in the Report
Adaptimmune Therapeutics Plc
Advenchen Laboratories LLC
CoBioRes NV
Epizyme Inc
GlaxoSmithKline Plc
Ignyta Inc
Immune Design Corp
Immunocore Ltd
Johnson & Johnson
Karyopharm Therapeutics Inc
Merck & Co Inc
Millennium Pharmaceuticals Inc
Novartis AG
OncoTherapy Science Inc
Pfizer Inc
Takara Bio Inc
Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/1301536-synovial-sarcoma-pipeline-review-5
Table of Contents
Table of Contents 2
Introduction 4
Synovial Sarcoma - Overview 5
Synovial Sarcoma - Therapeutics Development 6
Synovial Sarcoma - Therapeutics Assessment 14
Synovial Sarcoma - Companies Involved in Therapeutics Development 24
Synovial Sarcoma - Drug Profiles 32
Synovial Sarcoma - Dormant Projects 220
Synovial Sarcoma - Discontinued Products 221
Synovial Sarcoma - Product Development Milestones 222
Appendix 237List of Tables
Number of Products under Development for Synovial Sarcoma, H2 2018
Number of Products under Development by Companies, H2 2018
Number of
....Continued
View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1301536-synovial-sarcoma-pipeline-review-5
It's vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.
HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.
Contact US :
Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com
Connect with us at
https://www.linkedin.com/company/13388569/
https://plus.google.com/u/0/+NidhiBhawsar-SEO_Expert?rel=author
https://www.facebook.com/htfmarketintelligence/
https://twitter.com/htfmarketreport
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Synovial Sarcoma - Pipeline Review, H2 2018| Key players : Epizyme , GlaxoSmithKline Plc,Ignyta , Immune Design ,Immunocore here
News-ID: 1286096 • Views: …
More Releases from HTF Market Intelligence Consulting Pvt. Ltd.
AI Solutions in Engineering Market May Set a New Growth Story | Dolbey System, G …
According to HTF Market Intelligence, the Global AI Solutions in Engineering market to witness a CAGR of 49.82% during the forecast period (2025-2030). The Latest Released AI Solutions in Engineering Market Research assesses the future growth potential of the AI Solutions in Engineering market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment…
Livestock Monitoring Market to See Revolutionary Growth: GEA Group, Merck Animal …
According to HTF Market Intelligence, the Global Livestock Monitoring market to witness a CAGR of 15.4% during the forecast period (2025-2030). The Latest Released Livestock Monitoring Market Research assesses the future growth potential of the Livestock Monitoring market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
Thermoelectric Generators Market is in Huge Demand | Acal BFI, Adcol Electronic
According to HTF Market Intelligence, the Global Thermoelectric Generators market to witness a CAGR of 12.6% during the forecast period (2025-2030). The Latest Released Thermoelectric Generators Market Research assesses the future growth potential of the Thermoelectric Generators market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
Virtual Schools Market Current Status and Future Prospects| K12 Inc., Connection …
According to HTF Market Intelligence, the Global Virtual Schools market to witness a CAGR of 12.99% during the forecast period (2025-2030). The Latest Released Virtual Schools Market Research assesses the future growth potential of the Virtual Schools market and provides information and useful statistics on market structure and size.
This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and…
More Releases for Synovial
Synovial Sarcoma Market Clinical Advancements and Commercial Forecast
Synovial sarcoma is a rare, aggressive soft tissue cancer that typically arises near the joints of the arm or leg but can occur in other parts of the body. Although it accounts for less than 10% of all soft tissue sarcomas, synovial sarcoma often affects young adults and adolescents, making it a critical area of oncology research. Due to limited treatment options and poor survival outcomes, there has been an…
Synovial Sarcoma Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Synovial Sarcoma Pipeline Insight, 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Synovial Sarcoma pipeline landscape. It covers the Synovial Sarcoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Synovial Sarcoma pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Synovial…
Synovial Sarcoma Market Size, Share, Report and Forecast 2024-2032
The synovial sarcoma market size is anticipated to grow at a CAGR of 4% during the forecast period of 2024-2032, driven by increasing research activities in targeted therapy development.
Synovial Sarcoma: Introduction
Synovial sarcoma is a rare and aggressive type of soft tissue cancer, primarily affecting young adults. It often arises near large joints, especially the knees, though it can occur anywhere in the body. Despite its name, it's not related to…
Synovial Sarcoma Market Size, Trends, Industry Value and Latest Insights Till 20 …
What is the market size of synovial sarcoma?
The synovial sarcoma market reached a value of US$ 75.3 Million in 2023 and expected to reach US$ 114.0 Million by 2034, exhibiting a growth rate (CAGR) of 3.84% during 2024-2034.
Request for a Sample of this Report: https://www.imarcgroup.com/synovial-sarcoma-market/requestsample
Synovial Sarcoma Market Trends:
Synovial sarcoma is a rare and aggressive form of soft tissue cancer that primarily affects young adults. Despite its rarity, the market for…
Synovial Sarcoma Market Analysis: Growth, Trends, and Key Players
The Synovial Sarcoma Market is set for substantial expansion, with an anticipated Compound Annual Growth Rate (CAGR) of 4% during the forecast period spanning from 2024 to 2032. This growth can be attributed to various factors such as the increasing incidence of synovial sarcoma, advancements in medical technology, and the development of targeted therapies. In this comprehensive blog post, we will provide an in-depth overview of the Synovial Sarcoma Market,…
Synovial Sarcoma Market to Witness Growth by 2032, Estimates DelveInsight
DelveInsight's "Synovial Sarcoma Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Synovial Sarcoma, historical and forecasted epidemiology as well as the Synovial Sarcoma market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Synovial Sarcoma market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Synovial Sarcoma market size…
